- Home
- WAL vs LNTH Comparison
WAL vs LNTH Comparison
Compare WAL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAL | LNTH |
|---|---|---|
| Founded | 1994 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 4.4B |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | WAL | LNTH |
|---|---|---|
| Price | $86.61 | $65.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $99.33 | $78.00 |
| AVG Volume (30 Days) | 904.4K | ★ 1.1M |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | ★ 24.99 | N/A |
| EPS | ★ 8.09 | 2.39 |
| Revenue | ★ $3,189,400,000.00 | $1,525,933,000.00 |
| Revenue This Year | $16.21 | $0.01 |
| Revenue Next Year | $9.07 | $1.24 |
| P/E Ratio | ★ $10.73 | $27.10 |
| Revenue Growth | ★ 9.57 | 1.95 |
| 52 Week Low | $57.05 | $47.25 |
| 52 Week High | $94.40 | $111.29 |
Technical Indicators
Market Signals| Indicator | WAL | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 61.44 | 67.19 |
| Support Level | $85.14 | $64.13 |
| Resistance Level | $87.78 | $67.01 |
| Average True Range (ATR) | 2.28 | 2.17 |
| MACD | 0.15 | 0.32 |
| Stochastic Oscillator | 63.62 | 83.94 |
Price Performance
Historical ComparisonAbout WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.